SCHEMBL7385154

SCHEMBL7385154

CCOC(=O)C1=Cc2cccc(N)c2OCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
HSD17B10 Q99714 3/20 0.43
TLR8 Q9NR97 1/20 0.38
TLR7 Q9NYK1 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
CDC25B P30305 3/20 0.37
GAA P10253 3/20 0.37
MGAM O43451 1/20 0.37
AMY1A P0DUB6 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
MAPT P10636 4/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 3/20 0.36
RAB9A P51151 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7385304 0.87 MAPT (0.39) ALDH1A1CA12CA1CA2CA7
SCHEMBL7699846 0.86 TSHR (0.46) ALDH1A1HSD17B10CA12CA1CA2
SCHEMBL7696668 0.86 CA12 (0.48) ALDH1A1HSD17B10CA12CA1CA2
SCHEMBL7702347 0.85 PARP1 (0.50) ALDH1A1HSD17B10TLR8TLR7CA12
SCHEMBL7386364 0.85 CA12 (0.37) ALDH1A1HSD17B10TLR8TLR7CA12
SCHEMBL7698997 0.85 CYP4F2 (0.41) ALDH1A1CA12CA1CA2CA7
SCHEMBL7385104 0.85 NOTUM (0.40) ALDH1A1CA12CA1CA2CA7
SCHEMBL7702968 0.84 TSHR (0.41) ALDH1A1HSD17B10CA12CA1CA2
SCHEMBL7700639 0.84 ALDH1A1 (0.40) ALDH1A1CA12CA1CA2CA7
SCHEMBL7699554 0.83 CA2 (0.37) ALDH1A1TLR8TLR7CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346527-B1 1-BENZOXEPIN DERIVATIVES USED IN THE PREVENTION OF SODIUM AND HYDROGEN ION EXCHANGE; CARDIOVASCULAR, KIDNEY AND BRAIN DISORDER TREATMENT; ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-12 US disclosed
EP-1073650-A1 GUANIDINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-07 EP disclosed
WO-1999055690-A1 GUANIDINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-11-04 WO disclosed
WO-1998055475-A1 GUANIDINE DERIVIATIVES AS INHIBITORS OF NA+/H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed